跳至主要内容
临床试验/NCT03082560
NCT03082560Unknown不适用

Design and Validation of a New Assessment Tool for Lichen Planopilaris, the Boston Grade of Activity in Lichen Planopilaris (Boston GOAL)

Massachusetts General Hospital1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2017年2月10日最近更新:
适应症

试验速览

阶段
不适用
入组人数
40
试验地点
1
主要终点
Boston Grade of Activity in Lichen Planopilaris (Boston GOAL)

研究概览

简要总结

The study's Primary Objective is to design and validate a grading system for objective and accurate assessment of lichen planopilaris.

Secondary Objectives:

  • To assess change in symptoms such as pain and itch using a Numeric Rating Scale(NRS) scores and quality of life using the Dermatology Life Quality Index (DLQI) scores
  • To correlate this grading system with patient skin biopsies evaluating disease activity on a microscopic level
  • To correlate this grading system with digital global photography and trichoscopy

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female subjects in general good health between the ages of 18 and 80 years old
  • Clinical and histologic diagnosis of lichen planopilaris
  • Subject is able to understand and sign informed consent
  • Subject is able to complete the study and comply with study procedures
  • Subject has no known allergy to non-toxic ink
  • Subjects should be managed by an Massachusetts General Hospital dermatologist for their lichen planopilaris for the duration of the study

排除标准

  • Eligible subjects will be excluded from participation if they meet any of the following criteria:
  • Presence of dermatoses that might interfere with LPP diagnosis and/or evaluation such as seborrheic dermatitis or psoriasis
  • Other selected concomitant causes of hair loss, including discoid lupus erythematosus, central centrifugal cicatricial alopecia (CCCA), telogen effluvium
  • Abnormal TSH laboratory value >1 standard deviation above normal within last year
  • Any significant medical condition that may prevent the patient from participating in the study according to the investigator's assessment
  • Any known allergy to non-toxic ink Related to Biopsy
  • History of poor wound healing or blood-clotting abnormality
  • History of keloid formation or hypertrophic scarring
  • Regular intake of high doses of aspirin or anti-coagulant medications
  • Hypersensitivity to local anesthetics
  • History of poorly controlled diabetes mellitus
  • Pregnant, nursing or planning a pregnancy

结局指标

主要结局

Boston Grade of Activity in Lichen Planopilaris (Boston GOAL)

时间窗: 6 months

Design and validate a grading system for objective and accurate assessment of lichen planopilaris.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Maryanne Makredes Senna

Dermatologist

Massachusetts General Hospital

研究点 (1)

Loading locations...

相似试验